26.48
price up icon1.11%   0.2608
 
loading

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

pulisher
Nov 19, 2024

Royalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Victory Capital Management Inc. Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 19, 2024
pulisher
Nov 17, 2024

Amalgamated Bank Sells 48,057 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + - Seeking Alpha

Nov 16, 2024
pulisher
Nov 15, 2024

Royalty Pharma stock hits 52-week low at $25.2 amid market shifts - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week LowTime to Sell? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Simplify Asset Management Inc. Increases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

(RPRX) Technical Data - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Royalty Pharma Awards Inaugural Healthcare Prize to Michael Milken for Cancer Research Impact | RPRX Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade - The Motley Fool

Nov 14, 2024
pulisher
Nov 13, 2024

Ex-Dividend Reminder: Cencora, Royalty Pharma and Brookline Bancorp - Nasdaq

Nov 13, 2024
pulisher
Nov 13, 2024

Solid Earnings May Not Tell The Whole Story For Royalty Pharma (NASDAQ:RPRX) - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Syndax shares slide despite pivotal trial success - The Pharma Letter

Nov 13, 2024
pulisher
Nov 12, 2024

New South Capital Management Inc. Has $69.77 Million Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Los Angeles Capital Management LLC Lowers Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Van ECK Associates Corp Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Royalty Pharma Q3 2024 Earnings Preview - MSN

Nov 10, 2024
pulisher
Nov 10, 2024

Summit Global Investments Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Executive Wealth Management LLC - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Royalty Pharma Stock: Massive Opportunity Ahead (NASDAQ:RPRX) - Seeking Alpha

Nov 09, 2024
pulisher
Nov 08, 2024

Morgan Stanley's Strategic Reduction in Royalty Pharma PLC Holdi - GuruFocus.com

Nov 08, 2024
pulisher
Nov 07, 2024

Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Geron’s (GERN) RYTELO for $125M - StreetInsider.com

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Robeco Institutional Asset Management B.V. - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Royalty Pharma Reports Strong Q3 2024 Results - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Compared to Estimates, Royalty Pharma (RPRX) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Earnings call: Royalty Pharma reports robust Q3 growth, raises guidance By Investing.com - Investing.com Nigeria

Nov 06, 2024
pulisher
Nov 06, 2024

Royalty Pharma reports robust Q3 growth, raises guidance By Investing.com - ழ தொலைக்காட்சி

Nov 06, 2024
pulisher
Nov 06, 2024

Earnings call: Royalty Pharma reports robust Q3 growth, raises guidance - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Royalty Pharma Reports Third Quarter 2024 Results - ForexTV.com

Nov 06, 2024
pulisher
Nov 06, 2024

Royalty Pharma plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Royalty Pharma Q3 Soars: 15% Revenue Growth, $1.2B Deployment Drives Guidance Boost | RPRX Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 06, 2024

River Road Asset Management LLC Has $13.30 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Finance Watch: Syndax Raises $350m, KalVista Gets $100m In Royalty Deals - Citeline News & Insights

Nov 05, 2024
pulisher
Nov 05, 2024

Insights Ahead: Royalty Pharma's Quarterly Earnings - Benzinga

Nov 05, 2024
pulisher
Nov 05, 2024

Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Syndax agrees funding with Royalty Pharma for Niktimvo US sales - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Royalty Pharma plc and Syndax Pharmaceuticals Enter into $350 Million Royalty Funding Agreement for Niktimvo - Marketscreener.com

Nov 05, 2024
pulisher
Nov 05, 2024

Royalty Pharma (NASDAQ:RPRX) Upgraded at StockNews.com - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Syndax secures $350 million in royalty funding from Royalty Pharma By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™ - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

With 72% ownership, Royalty Pharma plc (NASDAQ:RPRX) boasts of strong institutional backing - Simply Wall St

Nov 04, 2024
pulisher
Nov 04, 2024

abrdn plc Reduces Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Trend Tracker for (RPRX) - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 03, 2024

Cannon Global Investment Management LLC Purchases Shares of 34,500 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 03, 2024
pulisher
Nov 03, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Blue Trust Inc. - Defense World

Nov 03, 2024
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):